Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Unspecified Adult Solid Tumor, Protocol Specific 1Sarcoma 1Osteosarcoma 1Chondrosarcoma 1Bone Neoplasms 1

Interventions

Irinotecan 16Paclitaxel 14Docetaxel 13Gemcitabine 12Cisplatin 12Capecitabine 8Oxaliplatin 7Temozolomide 6Leucovorin 6Fluorouracil 6Carboplatin 6Topotecan 5Chromatography, High Pressure Liquid 5Polymerase Chain Reaction 4Pharmacogenomic Testing 4Pemetrexed 4Immunohistochemistry 4Filgrastim 4Everolimus 4Etoposide 4Early Intervention, Educational 4Celecoxib 4tipifarnib 3ixabepilone 3bryostatin 1 3Tegafur 3Sorafenib 3Mass Spectrometry 3Magnetic Resonance Spectroscopy 3Lapatinib 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Unspecified Adult Solid Tumor, Protocol Specific × angiotensin I (1-7) × Clear all
NCT00471562 2017-08-01

Angiotensin-(1-7) in Treating Patients With Metastatic or Unresectable Solid Tumors

Wake Forest University Health Sciences

Phase 1 Completed
18 enrolled
Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific

Data powered by HemOnc (CC BY 4.0) Colophon âš¡